metaraminol has been researched along with Atrial Septal Defect in 1 studies
Metaraminol: A sympathomimetic agent that acts predominantly at alpha-1 adrenergic receptors. It has been used primarily as a vasoconstrictor in the treatment of HYPOTENSION.
metaraminol : A member of the class of phenylethanolamines that is 2-amino-1-phenylethanol substituted by a methyl group at position 2 and a phenolic hydroxy group at position 1. A sympathomimetic agent , it is used in the treatment of hypotension.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mackenzie, IM | 1 |
| Banning, A | 1 |
| Dyar, O | 1 |
1 other study available for metaraminol and Atrial Septal Defect
| Article | Year |
|---|---|
Pharmacologic exposure of an occult atrial septal defect.
Topics: Adrenergic Agents; Echocardiography, Transesophageal; Heart Septal Defects, Atrial; Humans; Male; Me | 2001 |